Bispecific Antibodies / AXC: Development, Manufacturing
About
The BioForum “Bispecific Antibodies / AXC: Development, Manufacturing and Regulatory Pathways”, delivered by BioMelbourne Network in collaboration with ProBio, will explore the development, manufacturing and regulatory pathways shaping the next wave of antibody-based therapeutics.With a focus on bispecific antibodies and selected antibody-X conjugate (AXC) modalities, including radiopharmaceutical drug conjugates (RDCs) and antibody-oligonucleotide conjugates (AOCs), the forum will examine both the promise of these approaches and the distinct challenges they present from preclinical through to clinical and commercial translation.
Bringing together international and local speakers, this hybrid BioForum will share practical insights into the challenges and opportunities of next-generation biologics. Delegates attending in person or online will gain valuable perspectives on design, manufacturability, scalability and regulatory strategy, and on how organisations are reducing development risk and advancing promising therapies towards approval.
Date
Thursday 28 May 2026 4:00 PM - 6:30 PM (UTC+10)Location
Davies Collison Cave
Level 1, 500 Bourke Street, Melbourne, CBD Victoria 3000
Contact Form
Bispecific Antibodies / AXC: Development, Manufacturing
Resend recently purchased tickets to our events to your email.
Enter email to start search
You can review the event organiser's terms and conditions here.